← ANALYSTS · TIPRANKS
Lisa Walter · RBC Capital
Hits
50%
33 of 66 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+3.0%
Over a year after the rating, TipRanks’ measure
Our companies rated now
10
Buy / hold / sell: 9 / 1 / 0
Upside of the analyst’s targets
+125.4%
Average over 10 current targets, to the last price
The market’s answer to the ratings
+0.2%
Day-0 move against SPY in the rating’s direction, average over 9 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 8on TipRanks 21:45 | VRDNIWMViridian Therapeutics · $2.2B | Reiterated | Buy | $38.00 | +99.7% | +1.1%next day −1.9% · 5 days +4.0% | ↗ |
| Oct 8on TipRanks 21:45 | KRYSIWMKrystal Biotech · $9.8B | Reiterated | Buy | $400 | +26.4% | +0.7%next day +0.2% · 5 days −2.6% | ↗ |
| Oct 8on TipRanks 09:05 | UTHRUnited Therapeutics · $23.3B | Reiterated | Buy | $677 → $708+4.6% | +32.8% | −1.8%next day +2.5% · 5 days +1.9% | ↗ |
| Oct 8on TipRanks 09:05 | MIRMIWMMirum Pharmaceuticals · $5.3B | Reiterated | Buy | $135 → $155+14.8% | +93.4% | +1.3%next day +5.1% · 5 days +1.6% | ↗ |
| Oct 8on TipRanks 08:10 | RYTMIWMRhythm Pharmaceuticals · $6.0B | Reiterated | Buy | $155 → $159+2.6% | +84.5% | +1.8%next day +0.7% · 5 days −1.6% | ↗ |
| Sep 30on TipRanks 14:30 | UTHRUnited Therapeutics · $23.3B | Reiterated | Buy | $677 | +27.0% | +12.8%next day +5.3% · 5 days −1.3% | ↗ |
| Sep 22on TipRanks 07:10 | VRDNIWMViridian Therapeutics · $2.2B | Reiterated | Buy | $36.00 → $38.00+5.6% | +99.7% | +2.5%next day −2.4% · 5 days −8.4% | ↗ |
| Sep 14on TipRanks 21:45 | RYTMIWMRhythm Pharmaceuticals · $6.0B | Reiterated | Buy | $155 | +79.9% | −5.1%next day +1.7% · 5 days +0.2% | ↗ |
| Aug 17on TipRanks 21:00 | EYPTIWMEyePoint Pharmaceuticals · $271M | Downgrade | Hold | $37.00 → $5.00−86.5% | +67.2% | +13.0%next day +15.0% · 5 days −8.3% | ↗ |
| Aug 14on TipRanks 08:35 | FDMTIWM4D Molecular Therapeutics · $711M | Reiterated | Buy | $35.00 | +188.3% | +4.8%next day +19.8% · 5 days +31.2% | ↗ |
| Aug 14on TipRanks 08:35 | KRYSIWMKrystal Biotech · $9.8B | Initiated | Buy | $400 | +26.4% | +1.4%next day +1.5% · 5 days +5.7% | ↗ |
| Aug 13on TipRanks Aug 14 08:35 | MGTXIWMMeiragtx Holdings · $950M | Reiterated | Buy | $26.00 → $27.00+3.8% | +190.9% | −2.9%next day +6.9% · 5 days +16.7% | ↗ |
| Aug 6on TipRanks Aug 7 07:06 | IRDIWMOpus Genetics · $337M | Reiterated | Buy | $10.00 → $9.00−10.0% | +134.4% | −1.4%next day −2.2% · 5 days −1.2% | ↗ |
| Aug 6on TipRanks 07:01 | MIRMIWMMirum Pharmaceuticals · $5.3B | Reiterated | Buy | $148 → $135−8.8% | +68.5% | −10.9%next day +6.3% · 5 days +3.7% | ↗ |
| Aug 3on TipRanks Aug 5 21:45 | OCULIWMOcular Therapeutix · $1.6B | Reiterated | Buy | $30.00 | +336.7% | +1.4%next day +0.5% · 5 days +8.0% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗